The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Assesment of SOX-17 gene promoter hypermethylation in hepatocellular carcinoma.
Leonidas Chelis
No relevant relationships to disclose
Ioanna Balgouranidou
No relevant relationships to disclose
Triantafyllia Koukaki
No relevant relationships to disclose
Prodromos Michailidis
No relevant relationships to disclose
Evagelos Christakidis
No relevant relationships to disclose
Nikolaos Xenidis
No relevant relationships to disclose
Kiriakos Amarantidis
No relevant relationships to disclose
Grigorios Trypsianis
No relevant relationships to disclose
Stylianos Kakolyris
No relevant relationships to disclose